Cash Flow Statement
Growth Metrics

Sintx Technologies (SINT) Accumulated Expenses (2013 - 2026)

Sintx Technologies' quarterly Accumulated Expenses came in at $892000.0 in Q1 2026, up 57.6% year-on-year from $566000.0 in Q1 2025, and up 111.37% quarter-over-quarter from $422000.0 in Q4 2025.

Sintx Technologies has reported Accumulated Expenses for 14 years, with the latest figure at $892000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 57.6% year-over-year to $892000.0; the trailing twelve-month figure through Mar 2026 stood at $892000.0 (up 57.6% YoY), and the FY2025 full-year result was $422000.0, up 5.5% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $892000.0, up from $422000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.6 million in Q4 2022, with the low at $215000.0 in Q2 2025.
  • Average Accumulated Expenses over 5 years is $829823.5, with a median of $832000.0 recorded in 2023.
  • Year-over-year, Accumulated Expenses jumped 102.83% in 2023 and plunged 74.65% in 2025.
  • Tracing SINT's Accumulated Expenses over 5 years: stood at $1.6 million in 2022, then tumbled by 62.3% to $610000.0 in 2023, then tumbled by 34.43% to $400000.0 in 2024, then climbed by 5.5% to $422000.0 in 2025, then surged by 111.37% to $892000.0 in 2026.
  • The last three Accumulated Expenses figures came in at $892000.0 (Q1 2026), $422000.0 (Q4 2025), and $494000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Sintx Technologies 8.71 Mn 6.82 Mn 144,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 892,000.00
Dec 31, 2025 422,000.00
Sep 30, 2025 1.05 Mn
Jun 30, 2025 585,000.00
Mar 31, 2025 1.16 Mn
Dec 31, 2024 986,000.00
Sep 30, 2024 1.10 Mn
Jun 30, 2024 848,000.00
Mar 31, 2024 2.04 Mn
Dec 31, 2023 1.40 Mn
Sep 30, 2023 1.75 Mn
Jun 30, 2023 701,000.00
Mar 31, 2023 1.50 Mn
Dec 31, 2022 1.62 Mn
Sep 30, 2022 673,000.00
Jun 30, 2022 1.55 Mn
Mar 31, 2022 833,000.00
Dec 31, 2021 724,000.00
Sep 30, 2021 1.61 Mn
Jun 30, 2021 1.27 Mn
Mar 31, 2021 690,000.00
Dec 31, 2020 909,000.00
Sep 30, 2020 646,000.00
Jun 30, 2020 603,000.00
Mar 31, 2020 354,000.00
Dec 31, 2019 1.27 Mn
Sep 30, 2019 454,000.00
Jun 30, 2019 413,000.00
Mar 31, 2019 374,000.00
Dec 31, 2018 838,000.00
Sep 30, 2018 336,000.00
Jun 30, 2018 967,000.00
Mar 31, 2018 1.11 Mn
Dec 31, 2017 477,000.00
Sep 30, 2017 2.36 Mn
Mar 31, 2017 259,000.00
Dec 31, 2016 3.18 Mn
Sep 30, 2016 562,000.00
Jun 30, 2016 592,000.00
Dec 31, 2015 867,000.00
Sep 30, 2015 3.11 Mn
Jun 30, 2015 3.19 Mn
Mar 31, 2015 3.12 Mn
Dec 31, 2014 1.00 Mn
Sep 30, 2014 936,000.00
Jun 30, 2014 957,000.00
Mar 31, 2014 283,000.00
Dec 31, 2013 989,000.00